Novogen Ltd. (NVGN)

[WHP03]

Press releases indicates "Orphan Designation", FDA Orphan Approval Status; Not Approved for Orphan Indication.

Innocent Semantics? Partial Story?

http://www.streetinsider.com/Corporate+News/CanTx+Granted+FDA+Orphan+Drug+Designation+for+Cantrixil+%28NVGN%29+/10476279.html

http://www.accessdata.fda.gov/scripts/opdlisting/oopd/OOPD_Results_2.cfm?Index_Number=474815

Search Orphan Drug Designations and Approvals
Developing Products for Rare Diseases & Conditions4 -
Orphan Designation Search
Generic Name: cantrixil
Trade Name: n/a
Date Designated: 04-20-2015
Orphan Designation: Treatment of ovarian cancer
Orphan Designation Status: Designated
FDA Orphan Approval Status: Not FDA Approved for Orphan Indication
Sponsor: CanTx, Inc.
5 Science Park
3rd Floor
New Haven, CT 06511